Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma

• Christos Sachpekidis,
• Maximilian Merz,
• Annette Kopp-Schneider,
• Anna Jauch,
• Marc-Steffen Raab,
• Sandra Sauer,
• Jens Hillengass,
• Hartmut Goldschmidt,
• Antonia Dimitrakopoulou-Strauss

Affiliations

Christos Sachpekidis

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany;Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Maximilian Merz

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany

Annette Kopp-Schneider

Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany

Anna Jauch

Institute for Human Genetics, University of Heidelberg, Heidelberg, Germany

Marc-Steffen Raab

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Sandra Sauer

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

Jens Hillengass

Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA

Hartmut Goldschmidt

Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany;National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany

Antonia Dimitrakopoulou-Strauss

Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany